[HTML][HTML] Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
Somatic mutations in certain tyrosine kinases have emerged as central 'drivers' of specific
cancers and these mutant proteins are proving to be excellent substrates for targeted …
cancers and these mutant proteins are proving to be excellent substrates for targeted …
[PDF][PDF] Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
M Ladanyi, W Pao - Modern Pathology, 2008 - academia.edu
Somatic mutations in certain tyrosine kinases have emerged as central 'drivers' of specific
cancers and these mutant proteins are proving to be excellent substrates for targeted …
cancers and these mutant proteins are proving to be excellent substrates for targeted …
[引用][C] Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
M Ladanyi, W Pao - Modern Pathology, 2008 - cir.nii.ac.jp
[引用][C] Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond.
M Ladanyi, W Pao - Modern Pathology, 2008 - search.ebscohost.com
Somatic mutations in certain tyrosine kinases have emerged as central 'drivers' of specific
cancers and these mutant proteins are proving to be excellent substrates for targeted …
cancers and these mutant proteins are proving to be excellent substrates for targeted …
Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
M Ladanyi, W Pao - … pathology: an official journal of the …, 2008 - pubmed.ncbi.nlm.nih.gov
Somatic mutations in certain tyrosine kinases have emerged as central'drivers' of specific
cancers and these mutant proteins are proving to be excellent substrates for targeted …
cancers and these mutant proteins are proving to be excellent substrates for targeted …
[HTML][HTML] Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
M Ladanyi, W Pao - Modern Pathology, 2008 - Elsevier
Somatic mutations in certain tyrosine kinases have emerged as central 'drivers' of specific
cancers and these mutant proteins are proving to be excellent substrates for targeted …
cancers and these mutant proteins are proving to be excellent substrates for targeted …
Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond.
M Ladanyi, W Pao - Modern Pathology: an Official Journal of the …, 2008 - europepmc.org
Somatic mutations in certain tyrosine kinases have emerged as central'drivers' of specific
cancers and these mutant proteins are proving to be excellent substrates for targeted …
cancers and these mutant proteins are proving to be excellent substrates for targeted …
[HTML][HTML] Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
M Ladanyi, W Pao - Modern Pathology, 2008 - modernpathology.org
Somatic mutations in certain tyrosine kinases have emerged as central 'drivers' of specific
cancers and these mutant proteins are proving to be excellent substrates for targeted …
cancers and these mutant proteins are proving to be excellent substrates for targeted …